Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular Discordance between Myeloid Sarcomas and Concurrent Bone Marrows Occurs in Actionable Genes and Is Associated with Worse Overall Survival.

The Journal of molecular diagnostics : JMD - 1 Mar 2020

Werstein Brian, Dunlap Jennifer, Cascio Michael J, Ohgami Robert S, Fan Guang, Press Richard, Raess Philipp W

Abstract excerpt

Myeloid sarcoma is a rare, architecture-effacing proliferation of myeloid blasts localized to an extramedullary site, with or without concurrent bone marrow involvement. Clonal heterogeneity results from acquisition of somatic mutations within different subclones of leukemic cells. It was hypothesized that clonal heterogeneity between myeloid sarcomas and concurrent bone marrow biopsies might be present, given...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Biopsy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Bone Marrow

Share to Gene Expression Profiling

Share to High-Throughput Nucleotide Sequencing

Share to Immunophenotyping

Share to Karyotype

Share to Oncogenes

Source

Identifiers

PMID: 31866570
DOI: 10.1016/j.jmoldx.2019.11.004

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular Discordance between Myeloid Sarcomas and Concurrent Bone Marrows Occurs in Actionable Genes and Is Associated with Worse Overall Survival.PMID 31866570Read ↗

Multiomic characterization, early detection, and therapeutic targeting of myeloid sarcomaSemantic proximity Read ↗

Detection of prognostically relevant mutations and translocations in myeloid sarcoma by next generation sequencingSemantic proximity Read ↗

Gene Mutations and Targeted Therapies of Myeloid Sarcoma.Semantic proximity Read ↗

Genomic analysis in myeloid sarcoma and comparison with paired acute myeloid leukemia.Semantic proximity Read ↗

Dissecting the Genetic and Non-Genetic Heterogeneity of Acute Myeloid Leukemia Using Next-Generation Sequencing and In Vivo ModelsSemantic proximity Read ↗

Myeloid sarcoma: An overview.Semantic proximity Read ↗

Can molecular patterns help to classify overlapping entities in myeloid neoplasms?Semantic proximity Read ↗

RNA sequencing of myeloid sarcoma, shed light on myeloid sarcoma stratification.Semantic proximity Read ↗

Clinicopathological characteristics of de novo and secondary myeloid sarcoma: A monocentric retrospective study.Semantic proximity Read ↗

Genomic and Immunogenomic Profiling of Extramedullary Acute Myeloid Leukemia Reveals Actionable Clonal Branching and Frequent Immune EditingSemantic proximity Read ↗

Clonal Evolution of Acute Myeloid Leukemia Revealed by High-Throughput Single-Cell GenomicsSemantic proximity Read ↗

Extramedullary Acute Myeloid Leukemia in the De Novo Setting: Clinicopathologic Characteristics, Molecular Analysis, and Treatment OutcomesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.